Positive Aspects, Negative Aspects and Challenges Associated with Stem Cell Therapy for COVID - 19: A Mini-review

Area of Science:

• Immunology
• Regenerative Medicine
• Infectious Diseases

Background:

• COVID-19 presents significant treatment challenges, particularly for severe respiratory cases.
• Mesenchymal stem cells (MSCs) possess immunomodulatory and regenerative properties with potential therapeutic applications.
• Existing COVID-19 treatments face scrutiny regarding short-term and long-term safety and efficacy.

Purpose of the Study:

• To review the potential benefits, drawbacks, and challenges of using Mesenchymal Stem Cell (MSC) therapy for COVID-19 management.
• To critically evaluate MSC therapy's safety, efficacy, feasibility, and financial considerations.
• To explore MSCs' role in mitigating the cytokine storm and promoting lung healing in severe COVID-19 patients.

Main Methods:

• Literature review and analysis of existing studies on MSC therapy in the context of COVID-19.
• Examination of MSC mechanisms, including cytokine modulation and immune response regulation.
• Assessment of clinical trial data and case reports regarding MSC transplantation in critically ill patients.

Main Results:

• MSCs demonstrate potential in counteracting the cytokine storm associated with severe COVID-19.
• MSC therapy may promote immune response regulation and facilitate the expression of growth factors.
• Evidence suggests MSCs can aid in restoring pulmonary vascular and alveolar linings, promoting lung healing.

Conclusions:

• Mesenchymal Stem Cell (MSC) therapy is a potential therapeutic option for severe COVID-19 patients with lung involvement.
• Further investigation into MSC therapy's safety, specificity, and scalability is crucial.
• Addressing challenges related to mass production and affordability is essential for widespread clinical adoption.